Related Experiment Video
Updated: Jun 4, 2025

Genome-wide Screen for miRNA Targets Using the MISSION Target ID Library
Published on: April 6, 2012
miR-198 targets TOPORS: implications for oral squamous cell carcinoma pathogenesis
Pankhuri Kaushik1, Radha Mishra1, Champaka Gopal2
1Department of Developmental Biology and Genetics, Indian Institute of Science, Bangalore, India.
Background:
miRNAs play a critical role in the progression of various diseases, including oral squamous cell carcinoma (OSCC), which represents a major health concern and is one of the leading causes for new cancer cases worldwide. The miRNA dysregulation causes havoc and could be attributed to various factors, with epigenetic silencing of tumor suppressor genes being a major contributor to tumorigenesis. In this study, we have explored the tumor suppressive role of miR-198 in OSCC.
Methods:
The tumor suppressive effect of miR-198 is established using miRNA analysis in OSCC cell lines, patient samples and xenograft nude mice model. The relationship between the miR-198 and TOPORS is explored using bioinformatics analyses, qRT-PCR, dual-luciferase reporter assay, Western blotting and cancer hall marks assays. The hypermethylation of the MIR198 promoter is confirmed using bisulfite sequencing PCR.
Results:
We have found miR-198 to be upregulated in OSCC cells treated with 5-Azacytidine, a known DNA methyltransferase inhibitor. Upregulation of miR-198 in 5-Azacytidine treated OSCC cells appears to be due to methylation of the MIR198 promoter. Using bioinformatics analysis and dual-luciferase reporter assay, we have identified TOPORS (TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase) as a novel gene target for miR-198. miR-198-mediated repression of TOPORS decreases cell proliferation and anchorage-independent growth and enhances apoptosis of OSCC cells, which is dependent on the presence of the 3'UTR in TOPORS. An inverse correlation between the expression levels of miR-198 and TOPORS is observed in OSCC patient samples, highlighting the biological relevance of their interaction. Delivery of a synthetic miR-198 mimic to OSCC cells results in a significant decrease in xenograft size in nude mice, potentiating its use in therapeutics.
Conclusions:
These results suggest that miR-198 is epigenetically silenced in OSCC, which promotes tumor growth, in part, by upregulating the levels of TOPORS.
Insights
MicroRNA-198 (miR-198) acts as a tumor suppressor in oral squamous cell carcinoma (OSCC). Epigenetic silencing of miR-198 promotes OSCC growth by upregulating TOPORS, suggesting miR-198 as a potential therapeutic agent.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- MicroRNAs (miRNAs) are crucial in disease progression, particularly in oral squamous cell carcinoma (OSCC).
- Dysregulation of miRNAs, including epigenetic silencing of tumor suppressors, contributes significantly to OSCC tumorigenesis.
- This study investigates the tumor-suppressive function of miR-198 in OSCC.
Purpose of the Study:
- To explore the tumor suppressive role of miR-198 in oral squamous cell carcinoma (OSCC).
- To investigate the epigenetic regulation of miR-198 and its downstream targets in OSCC.
- To evaluate the therapeutic potential of miR-198 in OSCC.
Main Methods:
- miRNA analysis in OSCC cell lines, patient samples, and xenograft models.
- Bioinformatics, qRT-PCR, dual-luciferase reporter assays, and Western blotting to study miR-198 and TOPORS interaction.
- Bisulfite sequencing PCR to confirm promoter methylation of MIR198.
Main Results:
- miR-198 is epigenetically silenced in OSCC, with promoter hypermethylation confirmed.
- TOPORS identified as a novel direct target of miR-198.
- miR-198 represses TOPORS, decreasing cell proliferation and enhancing apoptosis in OSCC cells.
- Synthetic miR-198 mimic significantly reduced tumor size in a xenograft mouse model.
Conclusions:
- Epigenetic silencing of miR-198 in OSCC promotes tumor growth, partly via TOPORS upregulation.
- miR-198 exhibits tumor-suppressive activity in OSCC.
- miR-198 holds therapeutic potential for OSCC treatment.
Related Concept Videos
MicroRNAs
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
PI3K/mTOR/AKT Signaling Pathway

